Reuters (01.10.12) - Wednesday, January 11, 2012
The Food and Drug Administration reports it has received
applications from drugmakers who wish to produce generic
versions of the HIV drugs Isentress (Merck & Co.) and Epivir
(GlaxoSmithKline). Isentress was approved for use in adult
patients in 2007; in December, FDA expanded its label,
allowing the drug to be used in children and adolescents. FDA
declined to disclose the names of the generic drug applicants.